These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31446075)

  • 1. New Insights into Beta-Cell GLP-1 Receptor and cAMP Signaling.
    Tomas A; Jones B; Leech C
    J Mol Biol; 2020 Mar; 432(5):1347-1366. PubMed ID: 31446075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Targeted RNAi Screen Identifies Endocytic Trafficking Factors That Control GLP-1 Receptor Signaling in Pancreatic β-Cells.
    Buenaventura T; Kanda N; Douzenis PC; Jones B; Bloom SR; Chabosseau P; Corrêa IR; Bosco D; Piemonti L; Marchetti P; Johnson PR; Shapiro AMJ; Rutter GA; Tomas A
    Diabetes; 2018 Mar; 67(3):385-399. PubMed ID: 29284659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone receptor membrane component 1 is a functional part of the glucagon-like peptide-1 (GLP-1) receptor complex in pancreatic β cells.
    Zhang M; Robitaille M; Showalter AD; Huang X; Liu Y; Bhattacharjee A; Willard FS; Han J; Froese S; Wei L; Gaisano HY; Angers S; Sloop KW; Dai FF; Wheeler MB
    Mol Cell Proteomics; 2014 Nov; 13(11):3049-62. PubMed ID: 25044020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and biased agonist-mediated reductions in β-arrestin recruitment prolong cAMP signaling at glucagon family receptors.
    Jones B; McGlone ER; Fang Z; Pickford P; Corrêa IR; Oishi A; Jockers R; Inoue A; Kumar S; Görlitz F; Dunsby C; French PMW; Rutter GA; Tan T; Tomas A; Bloom SR
    J Biol Chem; 2021; 296():100133. PubMed ID: 33268378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minireview: Signal bias, allosterism, and polymorphic variation at the GLP-1R: implications for drug discovery.
    Koole C; Savage EE; Christopoulos A; Miller LJ; Sexton PM; Wootten D
    Mol Endocrinol; 2013 Aug; 27(8):1234-44. PubMed ID: 23864649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of insulin secretion by GLP-1.
    Jones B; Bloom SR; Buenaventura T; Tomas A; Rutter GA
    Peptides; 2018 Feb; 100():75-84. PubMed ID: 29412835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.
    Yabe D; Seino Y
    Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells.
    Buenaventura T; Bitsi S; Laughlin WE; Burgoyne T; Lyu Z; Oqua AI; Norman H; McGlone ER; Klymchenko AS; Corrêa IR; Walker A; Inoue A; Hanyaloglu A; Grimes J; Koszegi Z; Calebiro D; Rutter GA; Bloom SR; Jones B; Tomas A
    PLoS Biol; 2019 Aug; 17(8):e3000097. PubMed ID: 31430273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive Allosteric Modulation of the Glucagon-like Peptide-1 Receptor by Diverse Electrophiles.
    Bueno AB; Showalter AD; Wainscott DB; Stutsman C; Marín A; Ficorilli J; Cabrera O; Willard FS; Sloop KW
    J Biol Chem; 2016 May; 291(20):10700-15. PubMed ID: 26975372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells.
    Lee YS; Jun HS
    Metabolism; 2014 Jan; 63(1):9-19. PubMed ID: 24140094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular physiology of glucagon-like peptide-1 insulin secretagogue action in pancreatic β cells.
    Leech CA; Dzhura I; Chepurny OG; Kang G; Schwede F; Genieser HG; Holz GG
    Prog Biophys Mol Biol; 2011 Nov; 107(2):236-47. PubMed ID: 21782840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Analysis of Orthosteric and Allosteric GLP-1R Agonists' Effects on Insulin Secretion from Healthy, Diabetic, and Recovered INS-1E Pancreatic Beta Cells.
    Reed J; Higginbotham V; Bain S; Kanamarlapudi V
    Int J Mol Sci; 2024 Jun; 25(12):. PubMed ID: 38928038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New screening strategy and analysis for identification of allosteric modulators for glucagon-like peptide-1 receptor using GLP-1 (9-36) amide.
    Nakane A; Gotoh Y; Ichihara J; Nagata H
    Anal Biochem; 2015 Dec; 491():23-30. PubMed ID: 26341912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical assessment of glucagon-like peptide 1 receptor (GLP-1R) expression in the pancreas of patients with type 2 diabetes.
    Kirk RK; Pyke C; von Herrath MG; Hasselby JP; Pedersen L; Mortensen PG; Knudsen LB; Coppieters K
    Diabetes Obes Metab; 2017 May; 19(5):705-712. PubMed ID: 28094469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 receptor is present in pancreatic acinar cells and regulates amylase secretion through cAMP.
    Hou Y; Ernst SA; Heidenreich K; Williams JA
    Am J Physiol Gastrointest Liver Physiol; 2016 Jan; 310(1):G26-33. PubMed ID: 26542397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acylation of the Incretin Peptide Exendin-4 Directly Impacts Glucagon-Like Peptide-1 Receptor Signaling and Trafficking.
    Lucey M; Ashik T; Marzook A; Wang Y; Goulding J; Oishi A; Broichhagen J; Hodson DJ; Minnion J; Elani Y; Jockers R; Briddon SJ; Bloom SR; Tomas A; Jones B
    Mol Pharmacol; 2021 Oct; 100(4):319-334. PubMed ID: 34315812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon-like peptide 1-potentiated insulin secretion and proliferation of pancreatic β-cells.
    Ma X; Guan Y; Hua X
    J Diabetes; 2014 Sep; 6(5):394-402. PubMed ID: 24725840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes and obesity treatment based on dual incretin receptor activation: 'twincretins'.
    Skow MA; Bergmann NC; Knop FK
    Diabetes Obes Metab; 2016 Sep; 18(9):847-54. PubMed ID: 27160961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GLP-1R mediates idebenone-reduced blood glucose in mice.
    Zhao X; Zeng Q; Yu S; Zhu X; Bin Hu ; Deng L; Zhang Y; Liu Y
    Biomed Pharmacother; 2024 Sep; 178():117202. PubMed ID: 39053424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Interplay of Glucagon-Like Peptide-1 Receptor Trafficking and Signalling in Pancreatic Beta Cells.
    Marzook A; Tomas A; Jones B
    Front Endocrinol (Lausanne); 2021; 12():678055. PubMed ID: 34040588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.